1. Inhaled Phosphodiesterase Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease

   • Dave Singh
   • Simon Lea
   • Alexander G. Mathioudakis

   Leading Article 03 November 2021 Pages: 1821 - 1830

   

2. The Effects of Osteoporotic and Non-osteoporotic Medications on Fracture Risk and Bone Mineral Density

   • Anna C. van der Burgh
   • Catherine E. de Keyser
   • Bruno H. Stricker

   Review Article Open access 01 November 2021 Pages: 1831 - 1858

   

3. Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?

   • Eduardo Mysler
   • Valderilio Feijó Azevedo
   • Laurent Peyrin-Biroulet

   Review Article Open access 27 October 2021 Pages: 1859 - 1879

   

4. Safety, Immunogenicity and Interchangeability of Biosimilar Monoclonal Antibodies and Fusion Proteins: A Regulatory Perspective

   • Pekka Kurki
   • Sean Barry
   • Elena Wolff-Holz

   Original Research Article Open access 01 October 2021 Pages: 1881 - 1896

   

5. Interchangeability of Biosimilars: Overcoming the Final Hurdles

   • Liese Barbier
   • Arnold G. Vulto

   Commentary 02 November 2021 Pages: 1897 - 1903

6. Avatrombopag: A Review in Thrombocytopenia

   • Anthony Markham

   Adis Drug Evaluation Open access 28 October 2021 Pages: 1905 - 1913

   

7. Donafenib: First Approval

   • Susan J. Keam
   • Sean Duggan

   AdisInsight Report 30 September 2021 Pages: 1915 - 1920

   

8. Belzutifan: First Approval

   • Emma D. Deeks

   AdisInsight Report 06 October 2021 Pages: 1921 - 1927

   

9. Disitamab Vedotin: First Approval

   • Emma D. Deeks

   AdisInsight Report 18 October 2021 Pages: 1929 - 1935

   

10. Difelikefalin: First Approval

    • Emma D. Deeks

    AdisInsight Report 21 October 2021 Pages: 1937 - 1944

    

11. Correction to: Contezolid: First Approval

    • Sheridan M. Hoy

    Correction 23 October 2021 Pages: 1945 - 1945

12. Correction to: Sotorasib: First Approval

    • Hannah A. Blair

    Correction Open access 23 October 2021 Pages: 1947 - 1947

13. Correction to: REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study

    • Christian Domingo Ribas
    • Teresa Carrillo Díaz
    • the REDES Study Group

    Correction Open access 21 October 2021 Pages: 1949 - 1951